Stock Information
Regenxbio Inc (RGNX)
Ticker Symbol: RGNX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $431.81 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.7541
Revenue (TTM): $3.29 M
Dividend Yield: N/A%
ROE: -103.12%
Latest News
-
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
Thu, May 7, 2026 7:06 AM
-
Nancy Pelosi Stock Tracker Highlights Claude's Pharma Earnings Play: 'Will Be Interesting To See How This One Plays Out'
Thu, May 7, 2026 4:55 AM
-
REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy
Wed, May 6, 2026 7:07 AM
Key Financials
Financial data not available
